Do estrogen receptor β polymorphisms play a role in the pharmacogenetics of estrogen signaling?

Current Pharmacogenomics and Personalized Medicine

Volumn 6, Issue 4, 2008, Pages 239-259

  Nott, Stephanie L ^a   Huang, Yanfang ^a   Fluharty, Brian R ^a   Sokolov, Anna M ^a   Huang, Melinda ^a   Co, Cathleen ^b   Muyan, Mesut ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ST JOHN FISHER COLLEGE   (United States)

Author keywords

Estrogen; Estrogen receptor ; Estrogen signaling; Pharmacogenetic; Polymorphisms

Indexed keywords

ALENDRONIC ACID; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE; TRANSCRIPTION FACTOR YY1;

ADJUVANT THERAPY; ALZHEIMER DISEASE; BONE DENSITY; BREAST CANCER; CORONARY ARTERY DISEASE; DNA METHYLATION; DNA POLYMORPHISM; DRUG RECEPTOR BINDING; ENDOMETRIOSIS; ENDOMETRIUM CANCER; EXON; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE SILENCING; GENETIC EPIGENESIS; HORMONE SUBSTITUTION; HUMAN; NONHUMAN; OSTEOPOROSIS; OVARY CANCER; OVARY INSUFFICIENCY; PHARMACOGENETICS; PHARMACOGENOMICS; POINT MUTATION; PREECLAMPSIA; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TESTIS DISEASE; TRANSLATION INITIATION;

EID: 67649363687     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/187569208786733820     Document Type: Review

References (235)

1. Ali, S. and Coombes, R. C. (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2, 101-112.
2. Almeida, S.; Franken, N.; Zandona, M. R.; Osorio-Wender, M. C. and Hutz, M. H. (2005) Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J. 5, 30-34.
3. Ansonoff, M. A. and Etgen, A. M. (1998) Estradiol elevates protein kinase C catalytic activity in the preoptic area of female rats. Endocrinology 139, 3050-3056.
4. Arko, B.; Prezelj, J.; Komel, R.; Kocijancic, A. and Marc, J. (2002) No major effect of estrogen receptor β gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis. J. Steroid Biochem. Mol. Biol. 81, 147-152.
5. Aschim, E. L.; Giwercman, A.; Stahl, O.; Eberhard, J.; Cwikiel, M.; Nordenskjold, A.; Haugen, T. B.; Grotmol, T. and Giwercman, Y. L. (2005) The RsaI polymorphism in the estrogen receptor-β gene is associated with male infertility. J. Clin. Endocrinol. Metab. 90, 5343-5348.
6. Assmann, G. and Schulte, H. (1992) Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am. J. Cardiol. 70, 10H-13H.
7. Bai, Y. and Giguere, V. (2003) Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Mol. Endocrinol. 17, 589-599.
8. Bardin, A.; Boulle, N.; Lazennec, G.; Vignon, F. and Pujol, P. (2004) Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 11, 537-551.
9. Batra, G. S.; Hainey, L.; Freemont, A. J.; Andrew, G.; Saunders, P. T.; Hoyland, J. A. and Braidman, I. P. (2003) Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) α and β in bone fractures from men and women. J. Pathol. 200, 65-73.
10. Beekman, J. M.; Allan, G. F.; Tsai, S. Y.; Tsai, M. J. and O'Malley, B. W. (1993) Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7, 1266-1274.
11. Beleza-Meireles, A.; Kockum, I.; Lundberg, F.; Soderhall, C. and Nordenskjold, A. (2007) Risk factors for hypospadias in the estrogen receptor 2 gene. J. Clin. Endocrinol. Metab. 92, 3712-3718.
12. Benecke, A.; Chambon, P. and Gronemeyer, H. (2000) Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep. 1, 151-157.
13. Braidman, I. P.; Hainey, L.; Batra, G.; Selby, P. L.; Saunders, P. T. and Hoyland, J. A. (2001) Localization of estrogen receptor β protein expression in adult human bone. J. Bone Miner. Res. 16, 214-220.
14. Brandenberger, A. W.; Tee, M. K. and Jaffe, R. B. (1998) Estrogen receptor α (ERα) and β (ERβ) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ERβ in neoplastic tissues. J. Clin. Endocrinol. Metab. 83, 1025-1028.
15. Brinkman, B. M. (2004) Splice variants as cancer biomarkers. Clin. Biochem. 37, 584-594.
16. Brzozowski, A. M.; Pike, A. C.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J. A. and Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
17. Bukovsky, A.; Caudle, M. R.; Cekanova, M.; Fernando, R. I.; Wimalasena, J.; Foster, J. S.; Henley, D. C. and Elder, R. F. (2003) Placental expression of estrogen receptor β and its hormone binding variant - comparison with estrogen receptor α and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cells. Reprod. Biol. Endocrinol. 1, 36.
18. Campbell, R. A.; Bhat-Nakshatri, P.; Patel, N. M.; Constantinidou, D.; Ali, S. and Nakshatri, H. (2001) Phosphatidylinositol 3-kinase/ AKT-mediated activation of estrogen receptor α: a new model for antiestrogen resistance. J. Biol. Chem. 276, 9817-9824.
19. Campbell-Thompson, M.; Lynch, I. J. and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Res. 61, 632-640.
20. Carbonell Sala, S.; Masi, L.; Marini, F.; Del Monte, F.; Falchetti, A.; Franceschelli, F. and Brandi, M. L. (2005) Genetics and pharmacogenetics of osteoporosis. J. Endocrinol. Invest. 28, 2-7.
21. Carter, A. M.; Sachchithananthan, M.; Stasinopoulos, S.; Maurer, F. and Medcalf, R. L. (2002) Prothrombin G20210A is a bifunctional gene polymorphism. Thromb. Haemost. 87, 846-853.
22. Castoria, G.; Barone, M. V.; Di Domenico, M.; Bilancio, A.; Ametrano, D.; Migliaccio, A. and Auricchio, F. (1999) Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 18, 2500-2510.
23. Castoria, G.; Migliaccio, A.; Bilancio, A.; Di Domenico, M.; de Falco, A.; Lombardi, M.; Fiorentino, R.; Varricchio, L.; Barone, M. V. and Auricchio, F. (2001) PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20, 6050-6059.
24. Chakravarti, A. (1999) Population genetics - making sense out of sequence. Nat. Genet. 21, 56-60.
25. Chang, E. C.; Frasor, J.; Komm, B. and Katzenellenbogen, B. S. (2006) Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147, 4831-4842.
26. Chen, H. W.; Lin, R. J.; Xie, W.; Wilpitz, D. and Evans, R. M. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98, 675-686.
27. Chen, Y. C.; Kraft, P.; Bretsky, P.; Ketkar, S.; Hunter, D. J.; Albanes, D.; Altshuler, D.; Andriole, G.; Berg, C. D.; Boeing, H.; Burtt, N.; Bueno-de-Mesquita, B.; Cann, H.; Canzian, F.; Chanock, S.; Dunning, A.; Feigelson, H. S.; Freedman, M.; Gaziano, J. M.; Giovannucci, E.; Sanchez, M. J.; Haiman, C. A.; Hallmans, G.; Hayes, R. B.; Henderson, B. E.; Hirschhorn, J.; Kaaks, R.; Key, T. J.; Kolonel, L. N.; LeMarchand, L.; Ma, J.; Overvad, K.; Palli, D.; Pharaoh, P.; Pike, M.; Riboli, E.; Rodriguez, C.; Setiawan, V. W.; Stampfer, M.; Stram, D. O.; Thomas, G.; Thun, M. J.; Travis, R. C.; Virtamo, J.; Trichopoulou, A.; Wacholder, S. and Weinstein, S. J. (2007) Sequence variants of estrogen receptor β and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol. Biomarkers Prev. 16, 1973-1981.
28. Chi, A.; Chen, X.; Chirala, M. and Younes, M. (2003) Differential expression of estrogen receptor β isoforms in human breast cancer tissue. Anticancer Res. 23, 211-216.
29. Collins, F. S.; Guyer, M. S. and Charkravarti, A. (1997) Variations on a theme: cataloging human DNA sequence variation. Science 278, 1580-1581.
30. Cowley, S. M. and Parker, M. G. (1999) A comparison of transcriptional activation by ERα and ERβ. J. Steroid Biochem. Mol. Biol. 69, 165-175.
31. Cox, D. G.; Bretsky, P.; Kraft, P.; Pharoah, P.; Albanes, D.; Altshuler, D.; Amiano, P.; Berglund, G.; Boeing, H.; Buring, J.; Burtt, N.; Calle, E. E.; Canzian, F.; Chanock, S.; Clavel-Chapelon, F.; Colditz, G. A.; Feigelson, H. S.; Haiman, C. A.; Hankinson, S. E.; Hirschhorn, J.; Henderson, B. E.; Hoover, R.; Hunter, D. J.; Kaaks, R.; Kolonel, L.; LeMarchand, L.; Lund, E.; Palli, D.; Peeters, P. H.; Pike, M. C.; Riboli, E.; Stram, D. O.; Thun, M.; Tjonneland, A.; Travis, R. C.; Trichopoulos, D. and Yeager, M. (2008) Haplotypes of the estrogen receptor β gene and breast cancer risk. Int. J. Cancer 122, 387-392.
32. Craig, M. C. and Murphy, D. G. (2007) Estrogen: effects on normal brain function and neuropsychiatric disorders. Climacteric. 10(Suppl 2), 97-104.
33. Critchley, H. O.; Henderson, T. A.; Kelly, R. W.; Scobie, G. S.; Evans, L. R.; Groome, N. P. and Saunders, P. T. (2002) Wild-type estrogen receptor (ERβ1) and the splice variant (ERβcx/β2) are both expressed within the human endometrium throughout the normal menstrual cycle. J. Clin. Endocrinol. Metab. 87, 5265-5273.
34. Deroo, B. J. and Korach, K. S. (2006) Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570.
35. Eastwood, H.; Brown, K. M.; Markovic, D. and Pieri, L. F. (2002) Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa. Mol. Psychiatry 7, 86-89.
36. Enmark, E. and Gustafsson, J. A. (1999) Oestrogen receptors - an overview. J. Intern. Med. 246, 133-138.
37. Enmark, E.; Pelto-Huikko, M.; Grandien, K.; Lagercrantz, S.; Lagercrantz, J.; Fried, G.; Nordenskjold, M. and Gustafsson, J. A. (1997) Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82, 4258-4265.
38. Faus, H. and Haendler, B. (2006) Post-translational modifications of steroid receptors. Biomed. Pharmacother. 60, 520-528.
39. Feigelson, H. S. and Henderson, B. E. (2000) Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention. Breast Cancer Res. 2, 277-282.
40. Forsti, A.; Zhao, C.; Israelsson, E.; Dahlman-Wright, K.; Gustafsson, J. A. and Hemminki, K. (2003) Polymorphisms in the estrogen receptor β gene and risk of breast cancer: no association. Breast Cancer Res. Treat. 79, 409-413.
41. Frasor, J.; Danes, J. M.; Komm, B.; Chang, K. C.; Lyttle, C. R. and Katzenellenbogen, B. S. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144, 4562-4574.
42. Fu, M.; Wang, C.; Zhang, X. and Pestell, R. (2003) Nuclear receptor modifications and endocrine cell proliferation. J. Steroid Biochem. Mol. Biol. 85, 133-138.
43. Fu, M.; Wang, C.; Zhang, X. and Pestell, R. G. (2004) Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem. Pharmacol. 68, 1199-1208.
44. Fujimura, T.; Takahashi, S.; Urano, T.; Ogawa, S.; Ouchi, Y.; Kitamura, T.; Muramatsu, M. and Inoue, S. (2001) Differential expression of estrogen receptor β (ERβ) and its C-terminal truncated splice variant ERβcx as prognostic predictors in human prostatic cancer. Biochem. Biophys Res. Commun. 289, 692-699.
45. Fujishita, A.; Nakane, P. K.; Koji, T.; Masuzaki, H.; Chavez, R. O.; Yamabe, T. and Ishimaru, T. (1997) Expression of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: an immunohistochemical and in situ hybridization study. Fertil. Steril. 67, 856-864.
46. Gammill, H. S. and Roberts, J. M. (2007) Emerging concepts in preeclampsia investigation. Front Biosci. 12, 2403-2411.
47. Ganry, O. (2005) Phytoestrogens and prostate cancer risk. Prev. Med. 41, 1-6.
48. Gennari, L.; Becherini, L.; Falchetti, A.; Masi, L.; Massart, F. and Brandi, M. L. (2002) Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. J. Steroid Biochem. Mol. Biol. 81, 1-24.
49. Gennari, L.; Merlotti, D.; De Paola, V.; Calabro, A.; Becherini, L.; Martini, G. and Nuti, R. (2005) Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol. 161, 307-320.
50. Gennari, L.; Merlotti, D.; Valleggi, F.; Martini, G. and Nuti, R. (2007) Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging 24, 361-379.
51. Georgiou, I.; Syrrou, M.; Bouba, I.; Dalkalitsis, N.; Paschopoulos, M.; Navrozoglou, I. and Lolis, D. (1999) Association of estrogen receptor gene polymorphisms with endometriosis. Fertil. Steril. 72, 164-166.
52. Gingeras, T. R. (2007) Origin of phenotypes: genes and transcripts. Genome Res. 17, 682-690.
53. Girault, I.; Andrieu, C.; Tozlu, S.; Spyratos, F.; Bieche, I. and Lidereau, R. (2004) Altered expression pattern of alternatively spliced estrogen receptor β transcripts in breast carcinoma. Cancer Lett. 215, 101-112.
54. Godsland, I. F. (2001) Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil. Steril. 75, 898-915.
55. Gold, B.; Kalush, F.; Bergeron, J.; Scott, K.; Mitra, N.; Wilson, K.; Ellis, N.; Huang, H.; Chen, M.; Lippert, R.; Halldorsson, B. V.; Woodworth, B.; White, T.; Clark, A. G.; Parl, F. F.; Broder, S.; Dean, M. and Offit, K. (2004) Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res. 64, 8891-8900.
56. Grady, D.; Applegate, W.; Bush, T.; Furberg, C.; Riggs, B. and Hulley, S. B. (1998) Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin. Trials 19, 314-335.
57. Grans, H.; Nilsson, M.; Dahlman-Wright, K. and Evengard, B. (2007) Reduced levels of oestrogen receptor β mRNA in Swedish patients with chronic fatigue syndrome. J. Clin. Pathol. 60, 195-198.
58. Gray, I. C.; Campbell, D. A. and Spurr, N. K. (2000) Single nucleotide polymorphisms as tools in human genetics. Hum. Mol. Genet. 9, 2403-2408.
59. Green, S.; Kumar, V.; Krust, A.; Walter, P. and Chambon, P. (1986a) Structural and functional domains of the estrogen receptor. Cold Spring Harbor Symp. Quan. Biol. 51, 751-758.
60. Green, S.; Walter, P.; Greene, G.; Krust, A.; Goffin, C.; Jensen, E.; Scrace, G.; Waterfield, M. and Chambon, P. (1986b) Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 24, 77-83.
61. Green, S.; Walter, P.; Kumar, V.; Krust, A.; Bornert, J. M.; Argos, P. and Chambon, P. (1986c) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320, 134-139.
62. Hakansson, A.; Westberg, L.; Nilsson, S.; Buervenich, S.; Carmine, A.; Holmberg, B.; Sydow, O.; Olson, L.; Johnels, B.; Eriksson, E. and Nissbrandt, H. (2005) Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor β on the susceptibility to Parkinson's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133, 88-92.
63. Hall, J. M.; Couse, J. F. and Korach, K. S. (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276, 36869-36872.
64. Hall, J. M. and Korach, K. S. (2002) Analysis of the molecular mechanisms of human estrogen receptors α and β reveals differential specificity in target promoter regulation by xenoestrogens. J. Biol. Chem. 277, 44455-44461.
65. Hall, J. M. and McDonnell, D. P. (1999) The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140, 5566-5578.
66. Hedelin, M.; Balter, K. A.; Chang, E. T.; Bellocco, R.; Klint, A.; Johansson, J. E.; Wiklund, F.; Thellenberg-Karlsson, C.; Adami, H. O. and Gronberg, H. (2006) Dietary intake of phytoestrogens, estrogen receptor-β polymorphisms and the risk of prostate cancer. Prostate 66, 1512-1520.
67. Heldring, N.; Pike, A.; Andersson, S.; Matthews, J.; Cheng, G.; Hartman, J.; Tujague, M.; Strom, A.; Treuter, E.; Warner, M. and Gustafsson, J. A. (2007) Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931.
68. Herrington, D. M. (2003) Role of estrogen receptor-α in pharmacogenetics of estrogen action. Curr. Opin. Lipidol. 14, 145-150.
69. Herrington, D. M. and Klein, K. P. (2001) Pharmacogenetics of estrogen replacement therapy. J. Appl. Physiol. 91, 2776-2784.
70. Herynk, M. H. and Fuqua, S. A. (2004) Estrogen receptor mutations in human disease. Endocr. Rev. 25, 869-898.
71. Hirata, S.; Shoda, T.; Kato, J. and Hoshi, K. (2001) The multiple untranslated first exons system of the human estrogen receptor β (ERβ) gene. J. Steroid Biochem. Mol. Biol. 78, 33-40.
72. Hirata, S.; Shoda, T.; Kato, J. and Hoshi, K. (2003) Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol. Metab. 14, 124-129.
73. Horvath, L. G.; Henshall, S. M.; Lee, C. S.; Head, D. R.; Quinn, D. I.; Makela, S.; Delprado, W.; Golovsky, D.; Brenner, P. C.; O'Neill, G.; Kooner, R.; Stricker, P. D.; Grygiel, J. J.; Gustafsson, J. A. and Sutherland, R. L. (2001) Frequent loss of estrogen receptor-β expression in prostate cancer. Cancer Res. 61, 5331-5335.
74. Huang, J.; Li, X.; Hilf, R.; Bambara, R. A. and Muyan, M. (2005) Molecular basis of therapeutic strategies for breast cancer. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 379-396.
75. Huang, J.; Li, X.; Qiao, T.; Bambara, R. A.; Hilf, R. and Muyan, M. (2006) A tale of two estrogen receptors (ERs): how differential ER-estrogen responsive element interactions contribute to subtype-specific transcriptional responses. Nucl. Recept. Signal. 4, e015.
76. Huang, J.; Li, X.; Yi, P.; Hilf, R.; Bambara, R. A. and Muyan, M. (2004) Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes. Mol. Cell Endocrinol. 218, 65-78.
77. Hulley, S.; Furberg, C.; Barrett-Connor, E.; Cauley, J.; Grady, D.; Haskell, W.; Knopp, R.; Lowery, M.; Satterfield, S.; Schrott, H.; Vittinghoff, E. and Hunninghake, D. (2002) Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/ progestin Replacement Study follow-up (HERS II). JAMA 288, 58-66.
78. Imamov, O.; Shim, G. J.; Warner, M. and Gustafsson, J. A. (2005) Estrogen receptor β in health and disease. Biol. Reprod. 73, 866-871.
79. Inoue, S.; Ogawa, S.; Horie, K.; Hoshino, S.; Goto, W.; Hosoi, T.; Tsutsumi, O.; Muramatsu, M. and Ouchi, Y. (2000) An estrogen receptor β isoform that lacks exon 5 has dominant negative activity on both ERα and ERβ. Biochem. Biophys. Res. Commun. 279, 814-819.
80. Jensen, E. V. and Jordan, V. C. (2003) The estrogen receptor: a model for molecular medicine. Clin. Cancer Res. 9, 1980-1989.
81. Ji, Q.; Liu, P. I.; Elshimali, Y. and Stolz, A. (2005) Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR. Mol. Cell Endocrinol. 229, 103-110.
82. Joe, I. and Ramirez, V. D. (2001) Binding of estrogen and progesterone-BSA conjugates to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the effects of the free steroids on GAPDH enzyme activity: physiological implications. Steroids 66, 529-538.
83. Jones, M. E. and Simpson, E. R. (2000) Oestrogens in male reproduction. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 14, 505-516.
84. Jordan, V. C. and Morrow, M. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr. Rev. 20, 253-278.
85. Kalnina, Z.; Zayakin, P.; Silina, K. and Line, A. (2005) Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42, 342-357.
86. Kim, J.; Kim, J. Y.; Song, K. S.; Lee, Y. H.; Seo, J. S.; Jelinek, J.; Goldschmidt-Clermont, P. J. and Issa, J. P. (2007) Epigenetic changes in estrogen receptor β gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim. Biophys. Acta 1772, 72-80.
87. Kim, S. and Misra, A. (2007) SNP genotyping: technologies and biomedical applications. Annu. Rev. Biomed. Eng. 9, 289-320.
88. Kitawaki, J.; Kado, N.; Ishihara, H.; Koshiba, H.; Kitaoka, Y. and Honjo, H. (2002) Endometriosis: the pathophysiology as an estrogen-dependent disease. J. Steroid Biochem. Mol. Biol. 83, 149-155.
89. Kleyn, P. W. and Vesell, E. S. (1998) Genetic variation as a guide to drug development. Science 281, 1820-1821.
90. Klinge, C. M. (2001) Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29, 2905-2919.
91. Kousteni, S.; Bellido, T.; Plotkin, L. I.; O'Brien, C. A.; Bodenner, D. L.; Han, L.; Han, K.; DiGregorio, G. B.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S.; Roberson, P. K.; Weinstein, R. S.; Jilka, R. L. and Manolagas, S. C. (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104, 719-730.
92. Kraus, W. L. and Kadonaga, J. T. (1998) p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12, 331-342.
93. Kraus, W. L.; McInerney, E. M. and Katzenellenbogen, B. S. (1995) Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. Proc. Natl. Acad. Sci. USA 92, 12314-12318.
94. Kraus, W. L. and Wong, J. (2002) Nuclear receptor-dependent transcription with chromatin. Is it all about enzymes? Eur. J. Biochem. 269, 2275-2283.
95. Krege, J. H.; Hodgin, J. B.; Couse, J. F.; Enmark, E.; Warner, M.; Mahler, J. F.; Sar, M.; Korach, K. S.; Gustafsson, J. A. and Smithies, O. (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. USA 95, 15677-15682.
96. Kuiper, G. G.; Carlsson, B.; Grandien, K.; Enmark, E.; Haggblad, J.; Nilsson, S. and Gustafsson, J. A. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
97. Kuiper, G. G. and Gustafsson, J. A. (1997) The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410, 87-90.
98. Kuiper, G. G.; Lemmen, J. G.; Carlsson, B.; Corton, J. C.; Safe, S. H.; van der Saag, P. T.; van der Burg, B. and Gustafsson, J. A. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139, 4252-4263.
99. Kuller, L. H. (2003) Hormone replacement therapy and risk of cardiovascular disease: implications of the results of the Women's Health Initiative. Arterioscler. Thromb. Vasc. Biol. 23, 11-16.
100. Kushner, P. J.; Agard, D. A.; Greene, G. L.; Scanlan, T. S.; Shiau, A. K.; Uht, R. M. and Webb, P. (2000) Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74, 311-317.
101. Lambert, J. C.; Harris, J. M.; Mann, D.; Lemmon, H.; Coates, J.; Cumming, A.; St-Clair, D. and Lendon, C. (2001) Are the estrogen receptors involved in Alzheimer's disease? Neurosci. Lett. 306, 193-197.
102. Lander, E. S. (1996) The new genomics: global views of biology. Science 274, 536-539.
103. Lannigan, D. A. (2003) Estrogen receptor phosphorylation. Steroids 68, 1-9.
104. Lau, H. H.; Ho, A. Y.; Luk, K. D. and Kung, A. W. (2002) Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women. Bone 31, 276-281.
105. Lau, K. M.; Mok, S. C. and Ho, S. M. (1999) Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc. Natl. Acad. Sci. USA 96, 5722-5727.
106. Leader, J. E.; Wang, C.; Popov, V. M.; Fu, M. and Pestell, R. G. (2006) Epigenetics and the estrogen receptor. Ann. N. Y. Acad. Sci. 1089, 73-87.
107. Leav, I.; Lau, K. M.; Adams, J. Y.; McNeal, J. E.; Taplin, M. E.; Wang, J.; Singh, H. and Ho, S. M. (2001) Comparative studies of the estrogen receptors β and α and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159, 79-92.
108. Lee, G. H.; Kim, S. H.; Choi, Y. M.; Suh, C. S.; Kim, J. G. and Moon, S. Y. (2007) Estrogen receptor β gene +1730 G/A polymorphism in women with endometriosis. Fertil. Steril. 88, 785-788.
109. Leung, Y. K.; Mak, P.; Hassan, S. and Ho, S. M. (2006) Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling. Proc. Natl. Acad. Sci. USA 103, 13162-13167.
110. Levin, E. R. (2002) Cellular functions of plasma membrane estrogen receptors. Steroids 67, 471-475.
111. Li, L. C.; Yeh, C. C.; Nojima, D. and Dahiya, R. (2000) Cloning and characterization of human estrogen receptor β promoter. Biochem. Biophys. Res. Commun. 275, 682-689.
112. Li, X.; Huang, J.; Fluharty, B. R.; Huang, Y.; Nott, S. L. and Muyan, M. (2008) What are comparative studies telling us about the mechanism of ERβ action in the ERE-dependent E2 signaling pathway? J. Steroid Biochem. Mol. Biol. 109, 266-272.
113. Li, X.; Huang, J.; Yi, P.; Bambara, R. A.; Hilf, R. and Muyan, M. (2004a) Single-chain estrogen receptors (ERs) reveal that the ERα/ β heterodimer emulates functions of the ERα dimer in genomic estrogen signaling pathways. Mol. Cell Biol. 24, 7681-7694.
114. Li, Y. C.; Korol, A. B.; Fahima, T. and Nevo, E. (2004b) Microsatellites within genes: structure, function, and evolution. Mol. Biol. Evol. 21, 991-1007.
115. Licznar, A.; Caporali, S.; Lucas, A.; Weisz, A.; Vignon, F. and Lazennec, G. (2003) Identification of genes involved in growth inhibition of breast cancer cells transduced with estrogen receptor. FEBS Lett. 553, 445-450.
116. Lin, Z. and Altman, R. B. (2004) Finding haplotype tagging SNPs by use of principal components analysis. Am. J. Hum. Genet. 75, 850-861.
117. Loven, M. A.; Wood, J. R. and Nardulli, A. M. (2001) Interaction of estrogen receptors α and β with estrogen response elements. Mol. Cell Endocrinol. 181, 151-163.
118. Luckhaus, C.; Spiegler, C.; Ibach, B.; Fischer, P.; Wichart, I.; Sterba, N.; Gatterer, G.; Rainer, M.; Jungwirth, S.; Huber, K.; Tragl, K. H.; Grünblatt, E.; Riederer, P. and Sand, P. G. (2006) Estrogen receptor β gene (ESRβ) 3′-UTR variants in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 20, 322-323.
119. Luisi, S.; Galleri, L.; Marini, F.; Ambrosini, G.; Brandi, M. L. and Petraglia, F. (2006) Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil. Steril. 85, 764-766.
120. Maguire, P.; Margolin, S.; Skoglund, J.; Sun, X. F.; Gustafsson, J. A.; Borresen-Dale, A. L. and Lindblom, A. (2005) Estrogen receptor β (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res. Treat. 94, 145-152.
121. Mandusic, V.; Nikolic-Vukosavljevic, D.; Tanic, N.; Kanjer, K.; Neskovic-Konstantinovic, Z.; Celeketic, D. and Dimitrijevic, B. (2007) Expression of estrogen receptor β wt isoform (ERβ1) and ERβΔ5 splice variant mRNAs in sporadic breast cancer. J. Cancer Res. Clin. Oncol. 133, 571-579.
122. Manson, J. E.; Hsia, J.; Johnson, K. C.; Rossouw, J. E.; Assaf, A. R.; Lasser, N. L.; Trevisan, M.; Black, H. R.; Heckbert, S. R.; Detrano, R.; Strickland, O. L.; Wong, N. D.; Crouse, J. R.; Stein, E. and Cushman, M. (2003) Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349, 523-534.
123. Mansur Ade, P.; Nogueira, C. C.; Strunz, C. M.; Aldrighi, J. M. and Ramires, J. A. (2005) Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch. Med. Res. 36, 511-517.
124. Maruyama, A.; Nakayama, T.; Sato, N.; Mizutani, Y.; Furuya, K. and Yamamoto, T. (2004) Association study using single nucleotide polymorphisms in the estrogen receptor β (ESR2) gene for preeclampsia. Hypertens. Res. 27, 903-909.
125. McDonnell, D. P. (1999) The Molecular Pharmacology of SERMs. Trends Endocrinol. Metab. 10, 301-311.
126. McEwen, B. (2002) Estrogen actions throughout the brain. Recent Prog. Horm. Res. 57, 357-384.
127. McInerney, E. M.; Tsai, M. J.; O'Malley, B. W. and Katzenellenbogen, B. S. (1996) Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc. Natl. Acad. Sci. USA 93, 10069-10073.
128. McIntyre, M. H.; Kantoff, P. W.; Stampfer, M. J.; Mucci, L. A.; Parslow, D.; Li, H.; Gaziano, J. M.; Abe, M. and Ma, J. (2007) Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms. Cancer Epidemiol. Biomarkers Prev. 16, 2233-2236.
129. McLeod, H. L.; Papageorgio, C. and Watters, J. W. (2003) Using genetic variation to optimize cancer chemotherapy. Clin. Adv. Hematol. Oncol. 1, 107-111.
130. Metivier, R.; Penot, G.; Carmouche, R. P.; Hubner, M. R.; Reid, G.; Denger, S.; Manu, D.; Brand, H.; Kos, M.; Benes, V. and Gannon, F. (2004) Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes. EMBO J. 23, 3653-3666.
131. Metivier, R.; Penot, G.; Hubner, M. R.; Reid, G.; Brand, H.; Kos, M. and Gannon, F. (2003) Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell. 115, 751-763.
132. Miller, M.; Seidler, A.; Moalemi, A. and Pearson, T. A. (1998) Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J. Am. Coll. Cardiol. 31, 1252-1257.
133. Moggs, J. G.; Murphy, T. C.; Lim, F. L.; Moore, D. J.; Stuckey, R.; Antrobus, K.; Kimber, I. and Orphanides, G. (2005) Anti-proliferative effect of estrogen in breast cancer cells that re-express ERα is mediated by aberrant regulation of cell cycle genes. J. Mol. Endocrinol. 34, 535-551.
134. Moore, J. T.; McKee, D. D.; Slentz-Kesler, K.; Moore, L. B.; Jones, S. A.; Horne, E. L.; Su, J. L.; Kliewer, S. A.; Lehmann, J. M. and Willson, T. M. (1998) Cloning and characterization of human estrogen receptor β isoforms. Biochem. Biophys. Res. Commun. 247, 75-78.
135. Morey, A. K.; Pedram, A.; Razandi, M.; Prins, B. A.; Hu, R. M.; Biesiada, E. and Levin, E. R. (1997) Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 138, 3330-3339.
136. Murphy, L. C.; Dotzlaw, H.; Leygue, E.; Coutts, A. and Watson, P. (1998) The pathophysiological role of estrogen receptor variants in human breast cancer. J. Steroid Biochem. Mol. Biol. 65, 175-180.
137. Murphy, L. C.; Dotzlaw, H.; Leygue, E.; Douglas, D.; Coutts, A. and Watson, P. H. (1997) Estrogen receptor variants and mutations. J. Steroid Biochem. Mol. Biol. 62, 363-372.
138. Murphy, L. C. and Watson, P. H. (2006) Is oestrogen receptor-β a predictor of endocrine therapy responsiveness in human breast cancer? Endocr. Relat. Cancer 13, 327-334.
139. Nadal, A.; Ropero, A. B.; Fuentes, E. and Soria, B. (2001) The plasma membrane estrogen receptor: nuclear or unclear? Trends Pharmacol. Sci. 22, 597-599.
140. Nettles, K. W.; Bruning, J. B.; Gil, G.; O'Neill, E. E.; Nowak, J.; Guo, Y.; Kim, Y.; DeSombre, E. R.; Dilis, R.; Hanson, R. N.; Joachimiak, A. and Greene, G. L. (2007) Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep. 8, 563-568.
141. Nilsson, M.; Naessen, S.; Dahlman, I.; Linden Hirschberg, A.; Gustafsson, J. A. and Dahlman-Wright, K. (2004) Association of estrogen receptor β gene polymorphisms with bulimic disease in women. Mol. Psychiatry 9, 28-34.
142. Nilsson, S. and Gustafsson, J. A. (2002a) Biological role of estrogen and estrogen receptors. Crit. Rev. Biochem. Mol. Biol. 37, 1-28.
143. Nilsson, S. and Gustafsson, J. A. (2002b) Estrogen receptor action. Crit. Rev. Eukaryot. Gene Expr. 12, 237-257.
144. Nilsson, S.; Makela, S.; Treuter, E.; Tujague, M.; Thomsen, J.; Andersson, G.; Enmark, E.; Pettersson, K.; Warner, M. and Gustafsson, J. A. (2001) Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565.
145. Nowotny, P.; Kwon, J. M. and Goate, A. M. (2001) SNP analysis to dissect human traits. Curr. Opin. Neurobiol. 11, 637-641.
146. Ntukidem, N. I.; Nguyen, A. T.; Stearns, V.; Rehman, M.; Schott, A.; Skaar, T.; Jin, Y.; Blanche, P.; Li, L.; Lemler, S.; Hayden, J.; Krauss, R. M.; Desta, Z.; Flockhart, D. A.; Hayes, D. F. and Consortium on Breast Cancer Pharmacogenomics. (2008) Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin. Pharmacol. Ther. 83, 702-710.
147. O'Donnell, L.; Robertson, K. M.; Jones, M. E. and Simpson, E. R. (2001) Estrogen and spermatogenesis. Endocr. Rev. 22, 289-318.
148. Ogawa, S.; Hosoi, T.; Shiraki, M.; Orimo, H.; Emi, M.; Muramatsu, M.; Ouchi, Y. and Inoue, S. (2000) Association of estrogen receptor β gene polymorphism with bone mineral density. Biochem. Biophys. Res. Commun. 269, 537-541.
149. Ogawa, S.; Inoue, S.; Watanabe, T.; Orimo, A.; Hosoi, T.; Ouchi, Y. and Muramatsu, M. (1998) Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res. 26, 3505-3512.
150. Olferiev, M.; Masuda, E.; Tanaka, S.; Blank, M. C. and Pricop, L. (2007) The role of activating protein 1 in the transcriptional regulation of the human FCGR2B promoter mediated by the -343 G -> C polymorphism associated with systemic lupus erythematosus. J. Biol. Chem. 282, 1738-1746.
151. Omoto, Y.; Eguchi, H.; Yamamoto-Yamaguchi, Y. and Hayashi, S. (2003) Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7. Oncogene 22, 5011-5020.
152. Omoto, Y.; Kobayashi, S.; Inoue, S.; Ogawa, S.; Toyama, T.; Yamashita, H.; Muramatsu, M.; Gustafsson, J. A. and Iwase, H. (2002) Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur. J. Cancer 38, 380-386.
153. Palmieri, C.; Lam, E. W.; Mansi, J.; MacDonald, C.; Shousha, S.; Madden, P.; Omoto, Y.; Sunters, A.; Warner, M.; Gustafsson, J. A. and Coombes, R. C. (2004) The expression of ERβcx in human breast cancer and the relationship to endocrine therapy and survival. Clin. Cancer Res. 10, 2421-2428.
154. Parker, M. G. (1998) Transcriptional activation by oestrogen receptors. Biochem. Soc. Symp. 63, 45-50.
155. Pedersen, S. B.; Bruun, J. M.; Hube, F.; Kristensen, K.; Hauner, H. and Richelsen, B. (2001) Demonstration of estrogen receptor subtypes α and β in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol. Cell Endocrinol. 182, 27-37.
156. Pedram, A.; Razandi, M.; Aitkenhead, M.; Hughes, C. C. and Levin, E. R. (2002) Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem. 277, 50768-50775.
157. Pedram, A.; Razandi, M.; Wallace, D. C. and Levin, E. R. (2006) Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell. 17, 2125-2137.
158. Peng, B.; Lu, B.; Leygue, E. and Murphy, L. C. (2003) Putative functional characteristics of human estrogen receptor-β isoforms. J. Mol. Endocrinol. 30, 13-29.
159. Peter, I.; Shearman, A. M.; Vasan, R. S.; Zucker, D. R.; Schmid, C. H.; Demissie, S.; Cupples, L. A.; Kuvin, J. T.; Karas, R. H.; Mendelsohn, M. E.; Housman, D. E. and Benjamin, E. J. (2005a) Association of estrogen receptor β gene polymorphisms with left ventricular mass and wall thickness in women. Am. J. Hypertens. 18, 1388-1395.
160. Peter, I.; Shearman, A. M.; Zucker, D. R.; Schmid, C. H.; Demissie, S.; Cupples, L. A.; Larson, M. G.; Vasan, R. S.; D'Agostino, R. B.; Karas, R. H.; Mendelsohn, M. E.; Housman, D. E. and Levy, D. (2005b) Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J. Hypertens. 23, 2193-2200.
161. Pike, A. C. (2006) Lessons learnt from structural studies of the oestrogen receptor. Best Pract. Res. Clin. Endocrinol. Metab. 20, 1-14.
162. Pike, A. C.; Brzozowski, A. M.; Hubbard, R. E.; Bonn, T.; Thorsell, A. G.; Engstrom, O.; Ljunggren, J.; Gustafsson, J. A. and Carlquist, M. (1999) Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist. EMBO J. 18, 4608-4618.
163. Pirskanen, M.; Hiltunen, M.; Mannermaa, A.; Helisalmi, S.; Lehtovirta, M.; Hanninen, T. and Soininen, H. (2005) Estrogen receptor β gene variants are associated with increased risk of Alzheimer's disease in women. Eur. J. Hum. Genet. 13, 1000-1006.
164. Poola, I.; Abraham, J. and Baldwin, K. (2002a) Identification of ten exon deleted ERβ mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor beta mRNA is distinct from that of estrogen receptor alpha. FEBS Lett. 516, 133-138.
165. Poola, I.; Abraham, J.; Baldwin, K.; Saunders, A. and Bhatnagar, R. (2005a) Estrogen receptors β4 and β5 are full length functionally distinct ERβ isoforms: cloning from human ovary and functional characterization. Endocrine 27, 227-238.
166. Poola, I.; Clarke, R.; DeWitty, R. and Leffall, L. D. (2002b) Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 94, 615-623.
167. Poola, I.; Fuqua, S. A.; De Witty, R. L.; Abraham, J.; Marshallack, J. J. and Liu, A. (2005b) Estrogen receptor α-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERβ1 and ERβ5: potential molecular targets for chemoprevention. Clin. Cancer Res. 11, 7579-7585.
168. Practice Committee of the American Society for Reproductive Medicine (2004) Endometriosis and infertility. Fertil. Steril. 82(Suppl 1), S40-45.
169. Price, R. H., Jr.; Butler, C. A.; Webb, P.; Uht, R.; Kushner, P. and Handa, R. J. (2001) A splice variant of estrogen receptor β missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation. Endocrinology 142, 2039-2049.
170. Prins, G. S. and Korach, K. S. (2008) The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73, 233-244.
171. Pujol, P.; Rey, J. M.; Nirde, P.; Roger, P.; Gastaldi, M.; Laffargue, F.; Rochefort, H. and Maudelonde, T. (1998) Differential expression of estrogen receptor-α and -β messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res. 58, 5367-5373.
172. Razandi, M.; Pedram, A.; Greene, G. L. and Levin, E. R. (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol. 13, 307-319.
173. Razandi, M.; Pedram, A. and Levin, E. R. (2000) Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14, 1434-1447.
174. Razandi, M.; Pedram, A.; Park, S. T. and Levin, E. R. (2003) Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278, 2701-2712.
175. Reid, G.; Hubner, M. R.; Metivier, R.; Brand, H.; Denger, S.; Manu, D.; Beaudouin, J.; Ellenberg, J. and Gannon, F. (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell. 11, 695-707.
176. Rexrode, K. M.; Ridker, P. M.; Hegener, H. H.; Buring, J. E.; Manson, J. E. and Zee, R. Y. (2007) Polymorphisms and haplotypes of the estrogen receptor-β gene (ESR2) and cardiovascular disease in men and women. Clin. Chem. 53, 1749-1756.
177. Rivadeneira, F.; van Meurs, J. B.; Kant, J.; Zillikens, M. C.; Stolk, L.; Beck, T. J.; Arp, P.; Schuit, S. C.; Hofman, A.; Houwing-Duistermaat, J. J.; van Duijn, C. M.; van Leeuwen, J. P.; Pols, H. A. and Uitterlinden, A. G. (2006) Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J. Bone Miner. Res. 21, 1443-1456.
178. Roberts, J. M. and Catov, J. M. (2008) Preeclampsia more than 1 disease: or is it? Hypertension 51, 989-990.
179. Roden, D. M.; Altman, R. B.; Benowitz, N. L.; Flockhart, D. A.; Giacomini, K. M.; Johnson, J. A.; Krauss, R. M.; McLeod, H. L.; Ratain, M. J.; Relling, M. V.; Ring, H. Z.; Shuldiner, A. R.; Weinshilboum, R. M. and Weiss, S. T. (2006) Pharmacogenomics: challenges and opportunities. Ann. Intern. Med. 145, 749-757.
180. Rosenkranz, K.; Hinney, A.; Ziegler, A.; Hermann, H.; Fichter, M.; Mayer, H.; Siegfried, W.; Young, J. K.; Remschmidt, H. and Hebebrand, J. (1998) Systematic mutation screening of the estrogen receptor β gene in probands of different weight extremes: identification of several genetic variants. J. Clin. Endocrinol. Metab. 83, 4524-4527.
181. Rossouw, J. E.; Anderson, G. L.; Prentice, R. L.; LaCroix, A. Z.; Kooperberg, C.; Stefanick, M. L.; Jackson, R. D.; Beresford, S. A.; Howard, B. V.; Johnson, K. C.; Kotchen, J. M.; Ockene, J. and Writing Group for the Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
182. Safe, S. (2001) Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62, 231-252.
183. Sand, P.; Luckhaus, C.; Schlurmann, K.; Gotz, M. and Deckert, J. (2002) Untangling the human estrogen receptor gene structure. J. Neural. Transm. 109, 567-583.
184. Scariano, J. K.; Simplicio, S. G.; Montoya, G. D.; Garry, P. J. and Baumgartner, R. N. (2004) Estrogen receptor β dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women. Calcif Tissue Int. 74, 501-508.
185. Schiessl, B.; Mylonas, I.; Hantschmann, P.; Kuhn, C.; Schulze, S.; Kunze, S.; Friese, K. and Jeschke, U. (2005) Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors α and β in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J. Histochem. Cytochem. 53, 1441-1449.
186. Schwabe, J. W.; Chapman, L.; Finch, J. T. and Rhodes, D. (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 75, 567-578.
187. Schwabe, J. W.; Neuhaus, D. and Rhodes, D. (1990) Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 348, 458-461.
188. Secreto, F. J.; Monroe, D. G.; Dutta, S.; Ingle, J. N. and Spelsberg, T. C. (2007) Estrogen receptor α/β isoforms, but not βcx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. J. Cell Biochem. 101, 1125-1147.
189. Setiawan, V. W.; Hankinson, S. E.; Colditz, G. A.; Hunter, D. J. and De Vivo, I. (2004) Estrogen receptor β (ESR2) polymorphisms and endometrial cancer (United States). Cancer Causes Control. 15, 627-633.
190. Shang, Y.; Hu, X.; DiRenzo, J.; Lazar, M. A. and Brown, M. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103, 843-852.
191. Shearman, A. M.; Karasik, D.; Gruenthal, K. M.; Demissie, S.; Cupples, L. A.; Housman, D. E. and Kiel, D. P. (2004) Estrogen receptor β polymorphisms are associated with bone mass in women and men: the Framingham Study. J. Bone Miner. Res. 19, 773-781.
192. Shen, L. X.; Basilion, J. P. and Stanton, V. P., Jr. (1999) Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc. Natl. Acad. Sci. USA 96, 7871-7876.
193. Shevde, N. K.; Bendixen, A. C.; Dienger, K. M. and Pike, J. W. (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc. Natl. Acad. Sci. USA 97, 7829-7834.
194. Shoda, T.; Hirata, S.; Kato, J. and Hoshi, K. (2002) Cloning of the novel isoform of the estrogen receptor β cDNA (ERβ isoform M cDNA) from the human testicular cDNA library. J. Steroid Biochem. Mol. Biol. 82, 201-208.
195. Silvestri, S.; Thomsen, A. B.; Gozzini, A.; Bagger, Y.; Christiansen, C. and Brandi, M. L. (2006) Estrogen receptor α and β polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 13, 451-461.
196. Simoncini, T.; Hafezi-Moghadam, A.; Brazil, D. P.; Ley, K.; Chin, W. W. and Liao, J. K. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407, 538-541.
197. Simpson, J. L. and Bischoff, F. Z. (2002) Heritability and molecular genetic studies of endometriosis. Ann. N. Y. Acad. Sci. 955, 239-251.
198. Skakkebaek, N. E.; Rajpert-De Meyts, E. and Main, K. M. (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972-978.
199. Soulez, M. and Parker, M. G. (2001) Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J. Mol. Endocrinol. 27, 259-274.
200. Sun, J.; Meyers, M. J.; Fink, B. E.; Rajendran, R.; Katzenellenbogen, J. A. and Katzenellenbogen, B. S. (1999) Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology 140, 800-804.
201. Sundarrajan, C.; Liao, W. X.; Roy, A. C. and Ng, S. C. (2001) Association between estrogen receptor-β gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J. Clin. Endocrinol. Metab. 86, 135-139.
202. Tang, M. X.; Jacobs, D.; Stern, Y.; Marder, K.; Schofield, P.; Gurland, B.; Andrews, H. and Mayeux, R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
203. Tateishi, Y.; Kawabe, Y.; Chiba, T.; Murata, S.; Ichikawa, K.; Murayama, A.; Tanaka, K.; Baba, T.; Kato, S. and Yanagisawa, J. (2004) Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. EMBO J. 23, 4813-4823.
204. Tateishi, Y.; Sonoo, R.; Sekiya, Y.; Sunahara, N.; Kawano, M.; Wayama, M.; Hirota, R.; Kawabe, Y.; Murayama, A.; Kato, S.; Kimura, K. and Yanagisawa, J. (2006) Turning off estrogen receptor β-mediated transcription requires estrogen-dependent receptor proteolysis. Mol. Cell Biol. 26, 7966-7976.
205. Taylor, A. H. and Al-Azzawi, F. (2000) Immunolocalisation of oestrogen receptor β in human tissues. J. Mol. Endocrinol. 24, 145-155.
206. Thellenberg-Karlsson, C.; Lindstrom, S.; Malmer, B.; Wiklund, F.; Augustsson-Balter, K.; Adami, H. O.; Stattin, P.; Nilsson, M.; Dahlman-Wright, K.; Gustafsson, J. A. and Gronberg, H. (2006) Estrogen receptor β polymorphism is associated with prostate cancer risk. Clin. Cancer Res. 12, 1936-1941.
207. Tora, L.; White, J.; Brou, C.; Tasset, D.; Webster, N.; Scheer, E. and Chambon, P. (1989) The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59, 477-487.
208. Treeck, O.; Pfeiler, G.; Horn, F.; Federhofer, B.; Houlihan, H.; Vollmer, A. and Ortmann, O. (2007a) Novel estrogen receptor β transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells. Mol. Cell Endocrinol. 264, 50-60.
209. Treeck, O.; Pfeiler, G.; Mitter, D.; Lattrich, C.; Piendl, G. and Ortmann, O. (2007b) Estrogen receptor β1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J. Endocrinol. 193, 421-433.
210. Tzukerman, M. T.; Esty, A.; Santiso-Mere, D.; Danielian, P.; Parker, M. G.; Stein, R. B.; Pike, J. W. and McDonnell, D. P. (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8, 21-30.
211. Von Low, E. C.; Perabo, F. G.; Siener, R. and Muller, S. C. (2007) Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo 21, 189-204.
212. Wakeling, A. E. (2000) Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocr. Relat. Cancer 7, 17-28.
213. Wakeling, A. E.; Nicholson, R. I. and Gee, J. M. (2001) Prospects for combining hormonal and nonhormonal growth factor inhibition. Clin. Cancer Res. 7, 4350s-4355s; discussion 4411s-4412s.
214. Wang, D. G.; Fan, J. B.; Siao, C. J.; Berno, A.; Young, P.; Sapolsky, R.; Ghandour, G.; Perkins, N.; Winchester, E.; Spencer, J.; Kruglyak, L.; Stein, L.; Hsie, L.; Topaloglou, T.; Hubbell, E.; Robinson, E.; Mittmann, M.; Morris, M. S.; Shen, N.; Kilburn, D.; Rioux, J.; Nusbaum, C.; Rozen, S.; Hudson, T. J.; Lipshutz, R.; Chee, M. and Lander, E. S. (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082.
215. Wang, Z.; Yoshida, S.; Negoro, K.; Kennedy, S.; Barlow, D. and Maruo, T. (2004) Polymorphisms in the estrogen receptor β gene but not estrogen receptor α gene affect the risk of developing endometriosis in a Japanese population. Fertil. Steril. 81, 1650-1656.
216. Waring, S. C.; Rocca, W. A.; Petersen, R. C.; O'Brien, P. C.; Tangalos, E. G. and Kokmen, E. (1999) Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52, 965-970.
217. Watters, J. W. and McLeod, H. L. (2003) Cancer pharmacogenomics: current and future applications. Biochim. Biophys. Acta 1603, 99-111. Webb, P.; Nguyen, P.; Shinsako, J.; Anderson, C.; Feng, W.; Nguyen, M. P.;
218. Chen, D.; Huang, S. M.; Subramanian, S.; McKinerney, E.; Katzenellenbogen, B. S.; Stallcup, M. R. and Kushner, P. J. (1998) Estrogen receptor activation function 1 works by binding p160 co-activator proteins. Mol. Endocrinol. 12, 1605-1618.
219. Westberg, L.; Baghaei, F.; Rosmond, R.; Hellstrand, M.; Landen, M.; Jansson, M.; Holm, G.; Bjorntorp, P. and Eriksson, E. (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women. J. Clin. Endocrinol. Metab. 86, 2562-2568.
220. Westberg, L.; Hakansson, A.; Melke, J.; Shahabi, H. N.; Nilsson, S.; Buervenich, S.; Carmine, A.; Ahlberg, J.; Grundell, M. B.; Schulhof, B.; Klingborg, K.; Holmberg, B.; Sydow, O.; Olson, L.; Johnels, E. B.; Eriksson, E. and Nissbrandt, H. (2004a) Association between the estrogen receptor β gene and age of onset of Parkinson's disease. Psychoneuroendocrinology. 29, 993-998.
221. Westberg, L.; Ho, H. P.; Baghaei, F.; Nilsson, S.; Melke, J.; Rosmond, R.; Holm, G.; Bjorntorp, P. and Eriksson, E. (2004b) Polymorphisms in oestrogen and progesterone receptor genes: possible influence on prolactin levels in women. Clin. Endocrinol. (Oxf). 61, 216-223.
222. Wilkinson, H. A.; Dahllund, J.; Liu, H.; Yudkovitz, J.; Cai, S. J.; Nilsson, S.; Schaeffer, J. M. and Mitra, S. W. (2002) Identification and characterization of a functionally distinct form of human estrogen receptor β. Endocrinology 143, 1558-1561.
223. Wood, L. D.; Parsons, D. W.; Jones, S.; Lin, J.; Sjoblom, T.; Leary, R. J.; Shen, D.; Boca, S. M.; Barber, T.; Ptak, J.; Silliman, N.; Szabo, S.; Dezso, Z.; Ustyanksky, V.; Nikolskaya, T.; Nikolsky, Y.; Karchin, R.; Wilson, P. A.; Kaminker, J. S.; Zhang, Z.; Croshaw, R.; Willis, J.; Dawson, D.; Shipitsin, M.; Willson, J. K.; Sukumar, S.; Polyak, K.; Park, B. H.; Pethiyagoda, C. L.; Pant, P. V.; Ballinger, D. G.; Sparks, A. B.; Hartigan, J.; Smith, D. R.; Suh, E.; Papadopoulos, N.; Buckhaults, P.; Markowitz, S. D.; Parmigiani, G.; Kinzler, K. W.; Velculescu, V. E. and Vogelstein, B. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113.
224. Xu, L.; Pan-Hammarstrom, Q.; Forsti, A.; Hemminki, K.; Hammarstrom, L.; Labuda, D.; Gustafsson, J. A. and Dahlman-Wright, K. (2003) Human estrogen receptor β548 is not a common variant in three distinct populations. Endocrinology 144, 3541-3546.
225. Yang, S. H.; Liu, R.; Perez, E. J.; Wen, Y.; Stevens, S. M., Jr.; Valencia, T.; Brun-Zinkernagel, A. M.; Prokai, L.; Will, Y.; Dykens, J.; Koulen, P. and Simpkins, J. W. (2004) Mitochondrial localization of estrogen receptor β. Proc. Natl. Acad. Sci. USA 101, 4130-4135.
226. Yi, P.; Bhagat, S.; Hilf, R.; Bambara, R. A. and Muyan, M. (2002a) Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses. Mol. Endocrinol. 16, 1810-1827.
227. Yi, P.; Driscoll, M. D.; Huang, J.; Bhagat, S.; Hilf, R.; Bambara, R. A. and Muyan, M. (2002b) The effects of estrogen-responsive element-and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ERα and ERβ. Mol. Endocrinol. 16, 674-693.
228. Yoneda, K.; Tanji, Y.; Ikeda, N.; Miyoshi, Y.; Taguchi, T.; Tamaki, Y. and Noguchi, S. (2002) Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan. Cancer Lett. 186, 223-230.
229. Zhang, K.; Calabrese, P.; Nordborg, M. and Sun, F. (2002) Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71, 1386-1394.
230. Zhang, W. and Yu, Y. Y. (2007) Polymorphisms of short tandem repeat of genes and breast cancer susceptibility. Eur. J. Surg. Oncol. 33, 529-534.
231. Zhang, X.; Leung, Y. K. and Ho, S. M. (2007) AP-2 regulates the transcription of estrogen receptor (ER)-β by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. Oncogene 26, 7346-7354.
232. Zhao, C.; Lam, E. W.; Sunters, A.; Enmark, E.; De Bella, M. T.; Coombes, R. C.; Gustafsson, J. A. and Dahlman-Wright, K. (2003) Expression of estrogen receptor β isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene 22, 7600-7606.
233. Zhao, C.; Xu, L.; Otsuki, M.; Toresson, G.; Koehler, K.; Pan-Hammarstrom, Q.; Hammarstrom, L.; Nilsson, S.; Gustafsson, J. A. and Dahlman-Wright, K. (2004) Identification of a functional variant of estrogen receptor β in an African population. Carcinogenesis 25, 2067-2073.
234. Zheng, S. L.; Zheng, W.; Chang, B. L.; Shu, X. O.; Cai, Q.; Yu, H.; Dai, Q.; Xu, J. and Gao, Y. T. (2003) Joint effect of estrogen receptor β sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res. 63, 7624-7629.
235. Zhu, X.; Leav, I.; Leung, Y. K.; Wu, M.; Liu, Q.; Gao, Y.; McNeal, J. E. and Ho, S. M. (2004) Dynamic regulation of estrogen receptor-β expression by DNA methylation during prostate cancer development and metastasis. Am. J. Pathol. 164, 2003-2012.